PPARs: Versatile targets for future therapy for obesity, diabetes and cardiovascular diseases

Drug News and Perspectives

Volumn 15, Issue 5, 2002, Pages 261-267

  Mukherjee, Ranjan ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; FIBRIC ACID DERIVATIVE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; RECEPTOR SUBTYPE; RETINOID X RECEPTOR; ROSIGLITAZONE; TROGLITAZONE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

CARDIOVASCULAR DISEASE; CONFORMATIONAL TRANSITION; DIABETES MELLITUS; DNA BINDING; GENE EXPRESSION; INSULIN RESISTANCE; KNOCKOUT MOUSE; LIGAND BINDING; LIPID METABOLISM; OBESITY; PROTEIN DOMAIN; PROTEIN INTERACTION; REVIEW;

EID: 0036074569     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2002.15.5.840038     Document Type: Review

References (64)

1. Nuclear hormone receptor coregulators in action: Diversity for shared tasks
2. The coregulator exchange in transcriptional functions of nuclear receptors
3. Coregulator codes of transcriptional regulation by nuclear receptors
4. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
5. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors
6. Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids
7. Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors
8. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
9. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors
10. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation
11. mPPAR gamma 2: Tissue-specific regulator of an adipocyte enhancer
12. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation
13. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators
14. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1
15. Differential transactivation and transrepression by PPAR and RXR ligands
16. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor
17. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay
18. The peroxisome proliferator-activated receptor: Retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs
19. The PPARs: From orphan receptors to drug discovery
20. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma
21. A ureido-thioisobutyric acid (GW9578) is a subtype-selective PPARalpha agonist with potent lipid-lowering activity
22. Peroxisome proliferation and hepatocarcinogenesis
23. Peroxisome proliferator-induced pleiotropic responses: Pursuit of a phenomenon
24. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators
25. Peroxisome proliferator-activated receptor (PPAR) alpha activation and its consequences in humans
26. Human peroxisome proliferator-activated receptor alpha (PPARalpha) supports the induction of peroxisome proliferation in PPARalpha-deficient mouse liver
27. Mechanism of action of fibrates on lipid and lipoprotein metabolism
28. Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol - The veterans affairs HDL intervention trial (VA-HIT)
29. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: The Bezafibrate Infarction Prevention (BIP) study
30. Secondary prevention of coronary heart disease: The role of fibric acids
31. PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells
32. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity
33. The peroxisome proliferator-activated receptor alpha (PPARalpha) regulates bile acid biosynthesis
34. Fenofibrate raises plasma homocysteine levels in the fasted and fed states
35. Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects
36. Activation of PPARdelta alters lipid metabolism in db/db mice
37. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport
38. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor
39. Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2 versus PPARgamma1 and activation with retinoid X receptor agonists and antagonists
40. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids
41. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
42. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: Model for congenital generalized lipodystrophy
43. Life without white fat: A transgenic mouse
44. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma
45. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation
46. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma
47. The hormone resistin links obesity to diabetes
48. Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor gamma activation has coordinate effects on gene expression in multiple insulin-sensitive tissues
49. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)
50. Nuclear receptors have distinct affinities for coactivators: Characterization by fluorescence resonance energy transfer
51. The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones
52. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists
53. Lessons from the glitazones: A story of drug development
54. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice
55. A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: Effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats
56. Structure of the PPAR alpha and -gamma ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family
57. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance
58. PPAR gamma is required for placental, cardiac, and adipose tissue development
59. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation
60. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
61. A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor gamma-activating properties
62. A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes
63. Potentiation of glucose uptake, in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: Evidence for selectivity in the downstream responses to PPAR gamma activation
64. Inhibition of RXR and PPAR gamma ameliorates diet-induced obesity and type 2 diabetes